*NCCN makes no warranties of any kind whatsoever regarding their content, use, or application, and disclaims any responsibility for their application or use in any way. See the NCCN Guidelines® for detailed recommendations.
Preferred interventions are based on efficacy, safety, and evidence.

1L=first line; carbo/etop=carboplatin/etoposide; ES-SCLC=extensive-stage small cell lung cancer; NCCN=National Comprehensive Cancer Network.